NECLIFE
Start SIP
Invest Now
Start SIP in NECLIFE
Performance
- Low
- ₹14
- High
- ₹14
- 52 Week Low
- ₹13
- 52 Week High
- ₹36
- Open Price₹14
- Previous Close₹14
- Volume120,520
- 50 DMA₹15.87
- 100 DMA₹16.63
- 200 DMA₹18.91
Investment Returns
- Over 1 Month -24.85%
- Over 3 Month -8.39%
- Over 6 Month -2.64%
- Over 1 Year -61.86%
Smart Investing Starts Here Start SIP with Nectar Lifesciences for Steady Growth!
Nectar Lifesciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -0.9
- PEG Ratio
- 0
- Market Cap Cr
- 306
- P/B Ratio
- 0.4
- Average True Range
- 0.59
- EPS
- 0
- Dividend Yield
- 0
- MACD Signal
- -1.17
- RSI
- 34.3
- MFI
- 43.27
Nectar Lifesciences Financials
Nectar Lifesciences Technicals
EMA & SMA
Current Price
₹13.64
-0.09
(-0.66%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹14.50
- 50 Day
- ₹15.87
- 100 Day
- ₹16.63
- 200 Day
- ₹18.91
Resistance and Support
13.65
- R3 14.08
- R2 13.94
- R1 13.79
- S1 13.50
- S2 13.36
- S3 13.21
Nectar Lifesciences Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-01-23 | Quarterly Results & Others | To consider other business matters. |
| 2025-11-14 | Quarterly Results | |
| 2025-08-14 | Quarterly Results & Others | To consider other business matters. |
| 2025-07-23 | Others | Inter alia amongst other items, the mode of rewarding of shareholders as contemplated in the explanatory statement to item no. 3 of Notice of 2025-26/01st EGM or matters related thereto. |
| 2025-07-07 | Audited Results |
Nectar Lifesciences F&O
About Nectar Lifesciences
- NSE Symbol
- NECLIFE
- BSE Symbol
- 532649
- Chairman & Managing Director
- Mr. Sanjiv Goyal
- ISIN
- INE023H01027
Similar Stocks to Nectar Lifesciences
Nectar Lifesciences FAQs
Nectar Lifesciences share price is ₹13 As on 12 February, 2026 | 05:05
The Market Cap of Nectar Lifesciences is ₹305.9 Cr As on 12 February, 2026 | 05:05
The P/E ratio of Nectar Lifesciences is -0.9 As on 12 February, 2026 | 05:05
The PB ratio of Nectar Lifesciences is 0.4 As on 12 February, 2026 | 05:05
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.